The CSF levels of the investigated tryptic peptides of synaptotagmin-1 were significantly higher in patients with MCI due to Alzheimer’s disease and patients with dementia due to Alzheimer’s disease compared with controls (Fig. 1). Here, SYT1 is linked to Alzheimer disease.